Mutant gene found to fuel cancer-promoting effects of inflammation

Mutant gene found to fuel cancer-promoting effects of inflammation
Chronic inflammation triggers colon cancer cell invasion. If mutant p53 is eliminated from the cells, the invasive potential is significantly reduced and resembles a state prior to immune signaling. Credit: UC San Diego

A human gene called p53, which is commonly known as the "guardian of the genome," is widely known to combat the formation and progression of tumors. Yet, mutant forms of p53 have been linked to more cases of human cancer than any other gene.

Investigating core mechanisms of how cells respond to their surroundings in the human body, biologists at the University of California San Diego have discovered new evidence about mutant p53 that may reshape our understanding of and ultimately how we treat cancer.

A study published in the journal Nature Communications led by Homa Rahnamoun in Shannon Lauberth's laboratory at UC San Diego's Division of Biological Sciences uncovered a new mechanism linking mutant p53 function to chronic inflammation—a long-term condition typically associated with a response in the body's immune system—which can be induced in situations ranging from stress to food consumption. Lauberth said increasing evidence supports the role of in the predisposition and progression of cancer, with some human tissues being more susceptible to tumor growth influenced by inflammation, including colon and breast cancers.

Through large-scale genomic analyses, the researchers discovered that mutant p53 amplifies the impact of inflammation leading to increases in the invasive behavior of cancer. Thus, rather than fighting tumor growth, mutant forms of p53 appear to be tapping into the body's immune response system to fuel pro-inflammatory responses that increase cancer growth.

"Our findings suggest the importance of considering the genetic alterations of an individual's cancer since this can influence the impact of inflammation on ," said Lauberth, an assistant professor in the Section of Molecular Biology. "Immune therapy has been helpful in terms of targeting cancer and decreasing tumor size but now we found that inflammatory mediators can instead orchestrate growth in harboring a mutation in p53. These findings make us really rethink the process of tumorigenesis and how we treat cancer."

Lauberth says this research can potentially help better define clinically relevant cellular targets and their responses in human cancer with the ultimate goal of aiding the development of target-based cancer screening and therapies.

Explore further

Editing genes one by one throughout colorectal cancer cell genome uncovers new drug target

More information: Homa Rahnamoun et al. Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling, Nature Communications (2017). DOI: 10.1038/s41467-017-01117-y
Journal information: Nature Communications

Citation: Mutant gene found to fuel cancer-promoting effects of inflammation (2017, October 19) retrieved 9 December 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments